{"id":"placebo-of-nifedipine","safety":{"commonSideEffects":[{"rate":"null","effect":"Edema"},{"rate":"null","effect":"Headache"},{"rate":"null","effect":"Dizziness"}]},"_chembl":{"chemblId":"CHEMBL193","moleculeType":"Small molecule","molecularWeight":"346.34"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Nifedipine is a dihydropyridine calcium channel blocker that selectively inhibits the influx of calcium ions into smooth muscle cells, leading to vasodilation and a subsequent decrease in blood pressure. This mechanism is particularly effective in treating hypertension and angina pectoris.","oneSentence":"Nifedipine is a calcium channel blocker that works by relaxing blood vessels and reducing blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:34.426Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Angina pectoris"}]},"trialDetails":[{"nctId":"NCT07146451","phase":"","title":"6-year Outcomes in Children After Nifedipine vs Placebo for Preterm Prelabor Rupture of Membranes at 22-33 Weeks","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-10-28","conditions":"Children Born to Mothers Enrolled in the TOCOPROM Trial","enrollment":480},{"nctId":"NCT03976063","phase":"PHASE3","title":"Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-10-07","conditions":"Preterm Premature Rupture of Membrane","enrollment":850},{"nctId":"NCT00817037","phase":"PHASE2","title":"Sitaxsentan in Proteinuric Chronic Kidney Disease","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2007-07-14","conditions":"Chronic Kidney Disease, Proteinuria, Blood Pressure","enrollment":27},{"nctId":"NCT04186598","phase":"NA","title":"Evaluating the Utility of Continuous Positive Airway Pressure in the Treatment of High Altitude Pulmonary Edema","status":"COMPLETED","sponsor":"CommonSpirit Health","startDate":"2020-01-20","conditions":"Continuous Positive Airway Pressure, High Altitude Pulmonary Edema","enrollment":64},{"nctId":"NCT04392375","phase":"PHASE4","title":"Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2020-06-09","conditions":"Preeclampsia Severe","enrollment":110},{"nctId":"NCT00810732","phase":"PHASE2","title":"Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects","status":"COMPLETED","sponsor":"Pfizer","startDate":"2007-05-09","conditions":"Chronic Kidney Disease","enrollment":27},{"nctId":"NCT05711810","phase":"PHASE4","title":"Medicine-induced Cardiac Hemodialysis on COVID-19","status":"COMPLETED","sponsor":"Yang I. Pachankis","startDate":"2023-01-02","conditions":"Severe Acute Respiratory Syndrome-related Coronavirus, Renal Dialysis, Vaccines","enrollment":1},{"nctId":"NCT02463357","phase":"PHASE4","title":"Three New Ideas to Protect Special Forces From the Stress of High Altitude","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2015-08","conditions":"Mountain Sickness","enrollment":148},{"nctId":"NCT02132533","phase":"PHASE3","title":"Nifedipine for Acute Tocolysis of Preterm Labor","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2014-05-05","conditions":"Preterm Labor","enrollment":88},{"nctId":"NCT02527109","phase":"PHASE2, PHASE3","title":"The Effect of Intra-anal Nifedipine, Used As Add-on to Conservative Therapy, on Pain in Patients With Anal Fissure","status":"COMPLETED","sponsor":"RDD Pharma Ltd","startDate":"2016-05","conditions":"Chronic Anal Fissure","enrollment":339},{"nctId":"NCT00486824","phase":"PHASE1, PHASE2","title":"Indomethacin Versus Nifedipine for Preterm Labor Tocolysis","status":"COMPLETED","sponsor":"Stanford University","startDate":"2007-04","conditions":"Obstetric Labor, Premature","enrollment":29},{"nctId":"NCT00223717","phase":"PHASE1","title":"Treatment of Supine Hypertension in Autonomic Failure","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2001-01","conditions":"Hypertension","enrollment":152},{"nctId":"NCT02047019","phase":"PHASE3","title":"Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil","status":"WITHDRAWN","sponsor":"Bayer","startDate":"2017-12-01","conditions":"Hypertension","enrollment":""},{"nctId":"NCT01303783","phase":"PHASE2","title":"Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-04","conditions":"Hypertension, Essential","enrollment":1381},{"nctId":"NCT02072291","phase":"PHASE2","title":"Nifedipine Treatment on Uterine Contractility in IVF","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","startDate":"2014-03","conditions":"Embryo Implantation","enrollment":90},{"nctId":"NCT03027674","phase":"EARLY_PHASE1","title":"Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud","status":"COMPLETED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2016-08","conditions":"Raynaud Phenomenon Due to Trauma, Raynaud Disease, System; Sclerosis","enrollment":10},{"nctId":"NCT00620724","phase":"PHASE2","title":"Tocolytic Therapy in Conservative Management of Symptomatic Placenta Previa","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2008-01","conditions":"Placenta Previa","enrollment":109},{"nctId":"NCT01586286","phase":"NA","title":"A Study Examining the Use of Vaginal Nifedipine With Pelvic Floor Physical Therapy for Levator Myalgia and Pelvic Pain","status":"WITHDRAWN","sponsor":"Vanderbilt University","startDate":"2012-07","conditions":"Levator Ani Syndrome","enrollment":""},{"nctId":"NCT01348880","phase":"PHASE1","title":"Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-05","conditions":"Erectile Dysfunction","enrollment":42},{"nctId":"NCT01068847","phase":"PHASE1","title":"Drug Discrimination in Methadone-Maintained Humans Study 3","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2010-02","conditions":"Drug Dependence","enrollment":9},{"nctId":"NCT00733239","phase":"PHASE1","title":"Drug Discrimination in Methadone-Maintained Humans Study 2","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2008-08","conditions":"Opioid Dependence","enrollment":15},{"nctId":"NCT00185952","phase":"NA","title":"Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.","status":"COMPLETED","sponsor":"Stanford University","startDate":"2001-11","conditions":"Obstetric Labor, Premature, Venous Thrombosis","enrollment":70},{"nctId":"NCT00593463","phase":"PHASE1","title":"Drug Discrimination in Methadone-Maintained Humans Study 1","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2006-09","conditions":"Drug Dependence","enrollment":40},{"nctId":"NCT01215708","phase":"PHASE3","title":"Effects of the Use of Adjuvant Drugs After Extracorporeal Shockwave Lithotripsy (ESWL) in Renal Calculus","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2006-08","conditions":"Renal Calculi","enrollment":136},{"nctId":"NCT00306462","phase":"NA","title":"Trial of Magnesium Sulfate Tocolysis Versus Nifedipine Tocolysis in Women With Preterm Labor","status":"TERMINATED","sponsor":"University of Cincinnati","startDate":"2006-03","conditions":"Premature Birth, Premature Labor","enrollment":33},{"nctId":"NCT00722215","phase":"PHASE1","title":"Endothelin Receptor Antagonism in Proteinuric Nephropathy","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2006-05","conditions":"Chronic Kidney Disease, Proteinuria","enrollment":22},{"nctId":"NCT00280462","phase":"NA","title":"Choroidal Blood Flow Regulation During Isometric Exercise: Effects of Ca2+-Channel Blockade","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2005-08","conditions":"Ocular Physiology, Regional Blood Flow","enrollment":21},{"nctId":"NCT00496184","phase":"PHASE3","title":"Efficacy Study of Topical Application of Nifedipine Cream to Treat Vulvar Vestibulitis","status":"COMPLETED","sponsor":"Western Galilee Hospital-Nahariya","startDate":"2006-04","conditions":"Vulvar Diseases, Vulvar Pain, Vestibulitis","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1154,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo of Nifedipine","genericName":"Placebo of Nifedipine","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nifedipine is a calcium channel blocker that works by relaxing blood vessels and reducing blood pressure. Used for Hypertension, Angina pectoris.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}